Zolbetuximab shows the promising therapeutic strategy for people with certain kinds of colorectal tumor. This monoclonal antibody specifically affects glypican-3 (GPC3), a molecule often found in excess on tumor cells https://stevemcuq986389.wikiexpression.com/user